Effect of Filgotinib, a Selective JAK1 Inhibitor, with or without Methotrexate in Patients with Rheumatoid Arthritis: Patient-Reported Outcomes
Arthritis Res Ther 2018; 20(1):57 doi: 10.1186/s13075-018-1541-z
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Arthritis Res Ther 2018; 20(1):57 doi: 10.1186/s13075-018-1541-z
Rheumatol Ther 2018 Jun; 5(1):283–91
Rheumatol Ther 2018 Jun; 5(1):203–14. DOI: 10.1007/s40744-018-0093-7
Rheumatology (Oxford) 2018 May; 57(5):900-908
Rheumatology (Oxford) 2018; 57(2):309–17
Int J Rheum Dis 2018; 21(2):402–14
Rheumatology (Oxford) 2018;57(1):84–91
Please click the links below to go to the CSF review of each paper.
J Rheumatol 2018 Apr; 45(4):456-464
Rheumatology (Oxford) 2017 Dec 1;56(12):2179-2189 doi: 10.1093/rheumatology/kex319